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1. INTRODUCTION  
Obesity is an important public health, economic and societal issue both 
worldwide and domestically. The ever-increasing number of people affected is 
becoming increasingly important not only in terms of the tasks of domestic 
health care system, but also regarding the financing. 
The continued and global spread of overweight and obesity also affects 
Hungary.  
Obesity management and prevention also have an economic impact. Costs 
cannot be determined exactly at population level and can only be estimated on an 
individual basis. Obesity causes complications, which can also be associated 
with costs. 
According to the World Health Organization, 80% of total deaths in the 
European Union are caused by non-communicable diseases. There is a strong 
correlation between higher BMI and total mortality; 5 kg/m² BMI increase 30% 
overall mortality increase, 40% increase in cardiovascular disease risk, 60-120% 
diabetes, kidney and liver disease risk increase and higher mortality. 
Disorders associated with nutrition and lifestyle (cardiovascular, tumour 
diseases, hypertension, diabetes, obesity) are among the leading diseases among 
the Hungarian population. 
Research has shown that diet plays an important role in preventing chronic 
diseases and obesity. With appropriate nutrient-rich diets and lifestyle patterns 
improvement could be achieved in the health of the population. 
The economic costs of obesity consist of direct, indirect, and intangible 
elements. Direct costs can be divided into medical and non-medical costs. 
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LITERATURE REVIEW 
The economic and financial crisis that began in 2008 has reorganized the 
economies, societies and health systems of developed countries. Newly emerging 
internal and external economic impacts have had a major impact on the health 
care system, short-, medium- and long-term priorities have shifted. In 2010, 
health spending fell in 10 of the 29 OECD member states, with spending less 
than 2% in 9 countries and more than 2% in 10 countries. 
In 2015, health expenditure in Hungary amounted to 7.2% of GDP. The EU 
average reached 8% in the same year. Approximately 3/4 of health spending is 
paid out of pocket in OECD countries. 
In recent decades, cardiovascular disease remains the first death in most 
OECD countries. Regarding the mortality rate of ischemic heart disease in 
Hungary, 288 deaths per hundred thousand inhabitants. Hungary is also the 
leader in mortality due to cerebral vascular diseases. The mortality caused by 
malignant tumors was over 200 in 2015 in the OECD countries per 100.000 
inhabitants. This rate was highest in Hungary, Slovakia and Slovenia. 
The health burden of the population is partly covered by health insurance. 
Health insurance does not cover all medical examinations, the extent of coverage 
has a significant impact on the level of individual contributions. 
Traditionally, Hungarian public health indicators are poor. The average life 
expectancy at birth is 5 years lower than the EU average, and 9 years shorter for 
the lower educated, compared to those with tertiary education. Just over half of 
the Hungarians consider themselves healthy, while this is much higher in the 
surrounding countries. The out of pocket payments of the population represent 
nearly a third of all health expenditure. 
The Health Survey in 2014 confirmed that the lifestyle that can be 
considered unhealthy for Hungarians plays a significant role in the development 
of chronic diseases. Losing life years as a result of deaths and fewer years of life 
in health is a greater burden for the individual, the family, and society. 
According to 2014 statistics, about 7.3% of the population, or about 
727.000 people, suffered from type 2 diabetes this year with female dominance. 
Increasing social involvement has also been reflected in a steady increase in the 
number of patients referred to the hospital and in the number of days spent in the 
hospital. The increased number of patients led to an increase in the cost of 
treating the disease group. 
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With the increase in obesity, the chronic diseases associated with obesity 
also increase and their proportion increases with age. In studies trying to estimate 
the physical inactivity cost, they generally use the so-called Population 
Attributable Risk (PAR) estimate. 
The composition and proportions of the cost of treating obesity are often 
analysed by the so-called Cost of Illness (COI) test method, based on 
expenditure on each disease.  
The total economic consequences of obesity are compounded by three 
costs: direct, indirect, and intangible costs. Direct costs can be further divided 
into medical and non-medical costs. Direct costs include the diagnostic and 
therapeutic costs of prevention, basic, outpatient and inpatient care. This 
category includes the cost of medicines and medical aids, the costs of 
rehabilitation, the costs of disease prevention. Indirect costs include those costs 
or income losses that result from a reduction in sickness capacity, reduced 
productivity, sick pay, invalidity pension, or death. We call intangible or 
personal costs that occur as a result of the disease, but their quantification is 
almost impossible. 
In healthcare, cost sharing is shared between 3 participants: the state, the 
insurer (s) and the individual. The burden on individual is usually much more 
extensive. In the case of obesity, in addition to medicines or medical aids, the 
costs of any surgical treatment (gastric narrowing), the individual wardrobe, 
special means of transport, and care costs should not be forgotten. 
Research has clearly shown that diet plays an important role in preventing 
chronic diseases and obesity. Appropriate diets and lifestyle patterns could 
significantly improve the health of the population.  
Nutrition and lifestyle related disorders (cardiovascular, tumour diseases, 
diabetes, obesity) are among the leading illnesses among the Hungarian 
population. 
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2. OBJECTIVES 
1. Conducting a representative epidemiological study by professionals in 
the framework of primary care, anthropometric survey, height, body 
weight, waist circumference, education, registration of metabolic 
diseases, BMI calculation. 
2. In our study, we wanted to examine the cost elements related to obesity 
within the Hungarian healthcare system based on the data of the year of 
2012 at the level of the national economy and public expenditures, as 
well as estimating the individual expenditures, and then summarizing 
their magnitude at national level. 
3. For a broader morbidity cycle regarding the year of 2013, the same data 
were analysed by other methods, comparing, and explaining 
differences. 
4. A comparative analysis was performed about the costs of 4 specific 
diets related to nutritional habits, compared to 
• the "traditional Hungarian" diet 
•  a weight-loss sample diet, 
•  a sample diet for diabetics, as well as 
•  the cost of buying a bio-food diet, taking into account the 
energy content of each diet and other expenditures on lifestyle. 
 
In our study, we were looking for answers to the question of the proportion 
of obesity prevalent in Hungary, its prevalence, its relationship with other 
illnesses, whether it is influenced by residence or education. 
We asked how much can the treatment of obesity and close co-morbidity be? 
Can the right diet and lifestyle change be a solution to prevent obesity? 
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3. METHODS 
3.1. Population anthropometric parameter survey 
Between September 2012 and April 2013, volunteers over 18 years of age 
were enrolled in GPs’ offices, occupational health examinations nationwide. It 
was an exclusion condition, a disease that affected the nutritional status. 
Inquiries were carried out by GPs and 224 practices were volunteered. We asked 
for the first 200 people to appear on the orders. The examined population can be 
considered nationally representative by the level of education, distribution of 
place of residence and age distribution. 
We asked for ethical permission for the test and (ETT-TUKEB 20928-I). 
The attending GPs received the detailed methodological description and the 
following data were measured and registered in an electronically sent table: 
• Body height [cm]-Patients on barefoot, measured with approved 
stadiometer,  
• Body weight [kg]-Measured using a regularly calibrated weighing 
machine,  
• Waist circumference [cm]-Using a professional tape 
• The presence or absence of metabolic disease (diabetes and/or 
hypertension) was also registered. 
• The participants’ highest achieved level of education:   
 not completed the 8-year elementary school (under),  
 completed only elementary school (primary),  
 graduated in secondary school and/or skilled worker 
qualification (secondary),  
 having university or college degree (higher). 
 
The WHO-established BMI categories were used in our survey. 
Regarding waist circumference, the upper limit of normal range was 94 cm for 
men and 80cm for women, the “risky” range was between 94-102 and 88-94 cm 
respectively, and abdominal obesity was diagnosed above these values. 
Statistical analyses were performed in Stata 9.2.programme. 
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3.2. In 2012, financial costs associated with obesity in public funded  
We analyzed data for 2012 on the financing of the healthcare system, 
documented by the National Health Insurance Fund, based on diagnoses of 
obesity and co-morbidity (hypertension, diabetes). 
The request for data covered the whole of inpatient and inpatient care. The 
data collection was based on the BNO codes of the diagnosed diseases, which in 
the case of obesity was E65-68, in case of diabetes E10-11, and in case of high 
blood pressure I10-15 BNO code. We also asked for the same amount of 
sickness benefit payments with 2012 BNO codes. 
The data collection covered drugs and medical aids caused by the diseases 
mentioned above. We analyzed the related National Health Insurance Fund 
grants and patient reimbursement fees. 
The cause of obesity was determined in 80% of diabetics, 60% in the case 
of high blood pressure. 
 
3.3. In 2013, financial costs associated with obesity in the public funded  
In 2013, further comorbidities were selected related to obesity, including 
diabetes (E10-11), hypertension (I 10-11), stroke (I 63-64), heart failure and 
ischemic heart disease (I 21-25), gonarthrosis (knee osteoarthritis) (M 17), breast 
cancer (C 50), ovarian cancer (C 56), colon cancer (C 18) and gall stone (K 56). 
The cost of drug therapy used to reduce cholesterol levels was also included in 
the analysis. The filtering was for drugs prescribed by the E78 BNO coding 
character. 
Based on the above, inpatients and outpatients have been opted out from the 
National Health Insurance Fund database and based on our BNO codes and 
diagnoses, for whom these disorders were the leading diagnosis in nursing 
account. In the case of medicines and medical aids, the analysis was based on the 
BNO code indicated on the prescription. 
Sickness benefit payments were also considered, although the amounts 
could not be broken down into defined and encoded diseases. 
Among the leading diagnosis, the cost of obesity was 100% for the 
calculation of direct medical costs, while the estimated costs of the other diseases 
were calculated using the risk factor-based ratio (PAR) of the average risk in the 
population by PAR% = [P (RR -1)] / [1 + P (RR-1)], where P is the population 
 9 
 
density ratio of obesity and RR is the relative risk of developing a certain disease 
among obese individuals.  
As regards macroeconomic data, the public figures of the Hungarian State 
Budget were provided as well as the official government pages containing the 
data of the Hungarian State Treasury. 
For both studies, the requested data was provided free of charge by the National 
Health Insurance Fund Strategic Analysis Department's public reclamation 
request. 
 
3.4.Comparison of cost of sample trends using nutrient composition 
and analysis software  
In our lifestyle and nutrition survey, we have compiled four different 3-day 
sample diets. We took into account the physical activity need, medication, and 
other expenditures of the disease groups. The costs were determined by the 
prices of the Hungarian Central Statistical Office database, which is roughly the 
same as Hungary's retail and wholesale prices. Sample diets were calculated 
using (Nutricomp®) nutritional and analytical software, which included the 
energy content and the ratio of ingredients as well. 
In low energy diets, the recommended energy input is 1.500-2.000 calories 
per day among people with an average body mass and with physical activity. 
"Traditional Hungarian" meals have an average daily energy content of about 
3.000 calories. This includes foods that are not recommended by professionals 
for their high caloric content and unhealthy composition. In case of bio-food 
consumption, the recommended energy input is 2.000 calories. Diabetic people 
with average anthropometric parameters consume 1.600-1.800 calories a day. 
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4.  RESULTS 
4.1. Survey of population anthropometric parameters 
Altogether, the data of 40.127 (16.449 men and 23.678 women) were 
analyzed. The average age of subjects in the study was 52.15 years (± SD: 
21.92). Coming from all parts of Hungary, the number of participating GPs was 
244, representing 3.5% of all primary care practices. The location and number of 
practices were as follows: Budapest, the capital of Hungary: 38, cities and towns: 
99, and villages: 107.  
Higher BMI groups can be observed in all categories. According to waist 
circumference, parameters of risk were identified among more men in rural than 
urban settings. In their fourth decade of life, the ratio of males at risk was much 
higher in the rural population and in the fifth one it was. A similar trend was 
observed among rural women in their forties and over 70 years of age. Fewer 
people with higher education were represented in the obese category. Men with a 
higher degree had the highest proportion among the overweight BMI group and 
also higher in the normal then in obese group, while females had the lowest 
record among the obese and the highest in the normal range. Similar results were 
found according to waist circumference. In the categories of obesity the there 
were inverse relations between odds ratios and degrees of education. In both 
genders, these differences were mostly statistically significant when comparing 
primary and other educational levels. The prevalence data for obesity was the 
highest in the villages (35.4%), the lowest in Budapest (28.9%). They 
represented the 32.5% of other urban and 28.6% of rural population. The 
incidence of registered metabolic morbidities (hypertension and diabetes) was 
different regarding type of domiciles, showing an inverse correlation with the 
number of inhabitants. These morbidities were also significantly correlated with 
levels of education and categories of BMIs, with strong relation to the increasing 
age.  
4.2.  Financial expenditure on obesity in the public funded care in 2012 
From direct costs, we examined the amount of social security support for 
patients diagnosed with obesity, diabetes and hypertension, inpatient institute 
studies, medical aids, and prescriptions as well. The sum of the fees paid by the 
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patient, both for medical aids and medicines, was classified as personal 
expenses. 
In 2012, there were 47.517 inpatient obese people and the cost of their 
treatment was HUF 10.023.903.000. Outpatient care was used by 112.579 obese 
people, which meant HUF 549.728.000 cost. The cost of 169.108 diabetics was 
HUF 55.712.657.000. The cost of outpatient 427.791 diabetics was HUF 
2.850.866.000. In the case of hypertension, there were 52.878 inpatient people, 
with a cost of HUF 160.965.095.000, while outpatient care was used by 
1.128.142 people, which meant HUF 7.019.320.000 in 2012. In the case of 
sickness benefit days related to obesity, there were 226 days among patients 
between 40 and 49 years, altogether 13 people used it with HUF 720.000 cost. In 
the age group of 50-59 years, 163 days were spent by 8 people on sick leave, 
which meant HUF 341.000. In the 40-49 years old age group, 514 diabetic 
patients spent 12.930 days of sick leave, the gross amount of which was HUF 
30.295.000. In the age group of 50-59 years, 817 people used 27.087 days. The 
gross amount of sickness benefit was HUF 71.168.000. There were 46 
hypertensive 40-49-year-olds patients, with a total amount of 1.488 sick leave 
and HUF 4.008.000 sickness benefit. There were 133 50-59-year-olds, and 3.396 
sick leave meant HUF 9.401.000. The therapeutic aids included in the obesity 
indication affected 110 people, the Social Security support was HUF 2.887.000 
and the fee of the patient was HUF 675.000. In the case of redeemed 
prescriptions, 3.901 people were supported by Social Security with an amount of 
HUF 16.532.000 and the fee paid by the patients was HUF 10.681.000. The 
medical aids for diabetics were HUF 5.587.221.000 with Social Security support 
and HUF 1.193.433.000 were paid for 165.003 people. The Social Security 
support of medicines can be accounted with HUF 28.859.362.000 and HUF 
5.342.307.000 patients fee and 564.733 diabetics. In case of hypertension, 5.256 
people received medical aids with a support of HUF 34.424.000 and HUF 
7.371.000 patient fee. In the field of medicines, 2.831.205 people redeemed a 
prescription with a Social Security support of HUF 35.945.924.000, and HUF 
27.590.559.000 patient fee. Nationally aggregated health insurance payments 
and patient fees for the examined disease groups as well as the prevalence data 
on obesity (80% for diabetes, 60% for hypertension) were calculated beside HUF 
207.450 million social security support, which meant that the amount HUF 
21.799 million was paid by patients in 2012. 
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This funding is 11.6% of total public health expenditure, 0.73% of gross 
domestic product (GDP). GDP was HUF 28.048.068 million in the year under 
review. 
4.3. Financial expenditure on obesity in the public funded care in 2013 
In the Hungarian hospitals in the year of 2013, 2.010.536 patients were 
diagnosed with obesity, diabetes, hypertension, heart failure and ischemic heart 
disease, stroke, gonarthrosis, colon cancer, breast cancer, ovarian cancer, and 
gall stone. HUF 60 million for obesity, HUF 3.253 million for diabetes, HUF 
2.434 million for hypertension, HUF 20.032 million for heart failure, HUF 9.922 
million for stroke, HUF 5.940 million for gonarthrosis, HUF 5.638 million for 
colon cancer, HUF 12.370 million for breast cancer, HUF 2.061 million for 
ovarian tumour, and HUF 4.724 million for gall stone were paid to inpatient care 
establishments. Outpatient care was used by 1.693.898 people. Obesity was HUF 
70 million, diabetes was HUF 1.760 million, hypertension was HUF 3.576 
million, heart failure was HUF 1.337 million, stroke was HUF 423 million, 
gonarthrosis was HUF 1.192 million, colon cancer was HUF 295 million, breast 
tumour was HUF 1.435 million, ovarian tumour was HUF 48 million, and gall 
stone was HUF 318 million cost. 
Redeeming a prescription happened in case of 5.528.818 people, with a 
total amount of HUF 43.029 million. Medical aids were needed for 192.846 
people in the amount of HUF 1.294 million. 
The number of days left out of work due to sick leave was 8.890.851 days, 
which amounted to HUF 24.083 million for sickness benefit. 
Funding by National Health Insurance Fund was HUF 58.986 million in case of 
overweight and obese patients, including the calculated prevalence of listed 
diseases, and a further HUF 25.209 million of financial contributions were made 
by patients. 
In case of obesity, National Health Insurance Fund funded outpatient and 
inpatient care, redeemed medications and medical aids costed HUF 156 million. 
These costs for diabetes mean HUF 16.124 million, accounting for 40% 
prevalence of obesity. In case of hypertension with 45% prevalence it means 
HUF 16.376 million, heart failure with 23% means HUF 6.094 million, stroke 
with 11% means HUF 1.138 million, gonarthrosis with 19% means HUF 1.528 
million, cholesterol lowering with 30% means HUF 4.940 million, sick leave 
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with 30% means HUF 7.225 million, colon cancer with 10% means HUF 694 
million, breast cancer with 12% means HUF 2.391 million, ovarian tumours with 
22% means HUF 534 million and gall stone with 35% means HUF 1.786 
million. Patients' financial contribution to prescribed medications and therapeutic 
aids in case of obesity is HUF 12 million, for diabetes it is HUF 2.870 million, 
for hypertension it is HUF 12.555 million, for heart failure it is HUF 520 million, 
for cholesterol lowering it is HUF 1.912 million, for gonarthrosis it is HUF 115 
million and it is HUF 7.225 million for sick leave. 
Concerning the management of diabetes in 2013, HUF 40.311 million was 
paid from the state and HUF 7.173 million from patients. This amounted to HUF 
47.484 million, representing 5.2% of total healthcare expenditure and 16% of the 
total medication refund budget. The total cost of diabetes is 0.16% of GDP. 
These amounts represent 9.3% (908.011 million HUF) of healthcare 
expenditures of the total state budget and 30% (296.024 million HUF) of the 
total medication reimbursement budget. 
The gross domestic product (GDP) at purchase price was HUF 29.846.300 
million in 2013. Adding the amount of health insurance and patient fees, this 
amount represents 0.28% of the current year's GDP. 
4.4. Cost of sample schedules compiled using nutrient composition and 
analysis software 
In case of weight reducing 3-day sample diet, the average daily cost of the 
meals is HUF 1.870. The cost of the consumed fluid is HUF 200/2 l, with the 
vitamin taken and the monthly cost of the gym, this diet is HUF 2.471 per day. 
Someone with a "traditional Hungarian" lifestyle has a daily intake of 
energy of 3.000 Kcal and the average cost of meals is HUF 2.211 per day. With 
he cost of consumed sweetened soft drinks, this diet can be calculated with a 
daily cost of HUF 2.800. 
In case of the consumption of bio-foods, the daily average cost of a meal 
with 2.200 Kcal is HUF 3.259. When purchasing bio medicinal waters, vitamins 
and gym season ticket, HUF 4.490 is the total daily cost. 
For diabetics, 1.600-1.800 Kcal is the recommended energy intake, which 
means HUF 2.054 cost of their meals, and with a supplementary cost of 
consumed liquid, vitamin, regular exercise and taken medicines, this cost arises 
to daily HUF 2.892. 
 14 
 
5. DISCUSSION 
Comparing the data of a quarter century ago, the BMI has become higher in 
all age categories and the distribution of the population also tended toward being 
overweight, moreover obese, resulting a 2-4-fold increase in the percentage of 
incidence in some age categories. This shift has been more prominent among 
males. Their BMIs have been higher from the middle decades, while earlier 
women used to have larger surplus, which means rearrangement between 
categories, a shift from being overweight to becoming obese. Significant 
differences were found between the educational level and BMI categories. 
Although there were fewer obese persons among the subjects with higher 
education, being overweight was common, while women with a higher degree 
were less obese. Registered metabolic morbidities were strongly correlated with 
BMIs and both were inversely related to the level of urbanization. 
In the financial year of 2012, the amount of public expenditures incurred in 
the Hungarian healthcare system for the obesity and overweight patients 
according to the calculation of public finance data was HUF 207 billion, with the 
addition of at least HUF 22 billion of individual expenditures. This funding is 
11.6% of total public healthcare expenditure, 0.73% of GDP. 
In 2013, this amount was nearly HUF 60 billion, which is 9.3% of the E-
Fund, 0.28% of GDP, increased by the financial contribution of patients, with an 
additional HUF 25 billion. 
There are significant differences in the funding data for the two years under 
review. The reason for this is that, for 2012, the National Health Insurance Fund 
provided the amount of the payment for all the cases where the named disease 
was encoded in the reports. Following the refinement of their data filtering 
methods in 2013, it was already possible to select only funding paid for inpatient 
care cases where the disease we have identified was reported as a leading 
diagnosis justifying nursing care. It is known that in clinical practice, in a 
specific case, it is not always easy to name the disease which is the most 
important from medical aspect at that particular moment in a potentially 
"multimorbid" patient. 
By squeezing the given funding amounts for the two years, there was no 
significant difference in the number of case-by-case benefits in case of outpatient 
care. Large differences in inpatient care can be traced back to the fact that, based 
on filter diagnosis, the real cost of care is not reflected due to co-morbidity. 
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Medical expenditure on obesity is difficult to estimate. It is not easier for a 
particular person, even in the case of a patient's burden. At national level, it can 
be safely stated that obesity-related expenditures are around 1% of the total 
domestic gross national product. 
Treatment and care of obesity and related illnesses are a significant part of 
Hungarian public healthcare expenditure, both from the aspects of budget and 
individuals. It is impossible to accurately measure the total cost of obesity, so we 
can only estimate the expected incidence of some chronic diseases and the 
proportion of obesity and overweight related diseases. These data cover only the 
direct costs of obesity, the indirect and intangible costs can hardly be estimated. 
Limiting factors 
In our estimations, we did not have data on primary care expenditures since 
there is a normative funding and there are no available data from private 
providers where overweight patients are paying for their care. 
The cost of doctor-visiting and hospitalization expenses is also difficult to 
quantify at the population level. 
We did not have any data on patient transport and emergency care and 
bariatric surgery either. No account was taken of the cost of dialysis, nor was 
there any data on possible IVF and gestational diabetes costs. 
Many anti-obesity products are available without prescription in 
pharmacies or on the Internet, which is a large and ever-growing segment of the 
"healing" market.  
We did not account for the loss of income due to long-term reduced work 
ability ("disability pensions"). Personal expenses can be different for each 
individual. 
The burdens of households are usually out of the calculations. Such items 
can also appear that overweight children are missing more from school, and their 
training, eating, and clothing may be costlier. Of course, not a single parent so 
obviously keeps these expenses accounted. 
Lifestyle changes, the cost of using sports facilities, the higher prices of 
low-fat products and other recommended diets are usually not among the indirect 
costs. Without data we could not measure the intangible costs of obesity. Lost 
cost of production also cannot be estimated. 
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Unfortunately, calculations were made difficult because there is a lack of 
reliable data on the PAR calculation method among the Hungarian population. 
The strength of our investigations was that it is the first truly comprehensive 
estimate of obesity-related healthcare, especially regarding public expenditure, 
based on reliable sources in Hungary. Based on the data received from the 
National Health Insurance Fund within the framework of the public interest data 
application, it was possible to use financial data linked to the diagnosis. 
Prevention as a cost reduction opportunity 
By emphasizing economic considerations, it is commonly argued that a 
"healthy" pre-obesity lifestyle, including the quality of nutrition and sports, is 
more expensive than a so-called traditional lifestyle which is accompanied by 
obesity. Long-term, even lifelong, physically active lifestyle means though cost 
to the individual, but it is likely to be at least equivalent because of the "saved" 
medication costs, but it is certainly a cost reduction factor in the healthcare 
system expenditures at the social level.  
The sedentary lifestyle of the Hungarian population is well-known. 
Three quarters of Hungary's population is physically inactive. 
Obesity and overweight often involve social exclusion, leading to a deterioration 
of the individual's quality of life, and stigmatization of society. 
Bariatric surgery is primarily concerned with morbid obesity, and in a short 
period of time a spectacular result can be achieved, but the organization's 
compensation mechanisms mean uncertainty in the long run. The need for drug 
therapy is indisputable, but currently available drugs are expensive. 
Often, we are talking about the phenomenon of "obesity paradox", but not 
always in the right context. In justified medical interventions due to obesity, not 
a rigorous categorization into the BMI category should be considered but a 
realistic health hazard for the person concerned. 
The importance of the role of primary care cannot be emphasized enough, 
which is why it would be necessary to reform it both in terms of methodology 
and practical medicine and financing. 
 In our examinations, we compared the dietary and lifestyle expenditures in 
the sample diets and the results obtained were set in descending order, with 
which the following conclusion can be drawn: 
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- The most expensive diet is made up from bio-foods because foods free of 
chemical and preservative had to be payed, and organic farming results in 
lower yields, it is more sensitive to weather changes, and foods free of 
preservatives are more perishable. 
- At second place, there is a diet recommended for diabetics. The resulting 
excessive weight predominantly precedes many years before the onset of 
diabetes and plays a decisive role in triggering it, so it is important to 
prevent the onset of the disease. There are at least 772.000 known diabetics 
in Hungary, and most of them have excess body mass. For overweight 
diabetics, weight reduction and, if possible, normalization would be 
essential. The earlier this is done, the more the life expectancies of the 
individual will improve: favourably, even the diabetes itself can regress, but 
at least it can be more easily balanced.  So, the main treatment of overweight 
diabetes is a diet therapy. The diet is also important for insulin-treated 
diabetics because the effect curve of the insulin preparations used does not 
cover the elevated blood glucose elevations caused by carbohydrates 
absorbed from food even in the most up-to-date formulations. For diabetic 
patients without insulin-treatment, it is important because insulin secretion is 
slow during meals and cannot fully exert its effect due to insulin resistance. 
- Third place in terms of cost, there are sedentary, high-calorie diets. 
Consumption of inadequate quality and quantity of food contributes to 
overweight. Inadequate patterns of bad nutrition are also passed on to our 
children.  
- The most cost-effective is a balanced diet with low energy content. It would 
be possible to prevent obesity and the development of diabetes as well as 
nutrition and life-style related chronic diseases and it could improve the 
quality of life. 
In this estimate, it should be mentioned as a limiting factor that the 
recommended sample diet is not necessarily realized, and individuals use a very 
varied diet and nutritional habits throughout their lives. 
Treatment requires a broader, more consistent co-operation between society 
and the government, including the provision of resources as well. It would be 
beneficial to transform the primary healthcare system on a professional basis and 
to ensure the conditions for prevention. 
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 In Hungary, the spread of "obesity pandemic" remains a real danger, and 
this is a large number of tasks to be solved by the population, government, 
stakeholders and primarily the healthcare system. 
 It is clear that it prevention is economically the least expensive even on the 
basis of the cost analysis of the diets presented by us. Much more resources 
could be reallocated within healthcare if less treatment of obesity-related disease 
would be needed. 
Our calculations were based on estimates made from more accurate data 
from publicly funded healthcare, with the method of continuously corrected data. 
These were modified by textbook and literature population prevalence (PAR) 
data. In addition, we had to count the imitation factors listed above. So, in 
addition to the exact data, in many areas only estimates and calculations could be 
left. Based on these, public and individual expenditures related to obesity and 
overweight are estimated to be close to 1% of the gross domestic product of the 
year, which may account for nearly a fifth of the E-Fund. 
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6. SUMMARY 
Similarly to the global context, the economic burden of obesity and 
overweight in our country is becoming increasingly significant, and the amount 
spent on these diseases and complications within health spending is constantly 
increasing year by year.  
In our anthropometric survey, BMI values in each age group showed an 
increase compared to the 30-year study. The higher proportion of overweight 
people became obese. The highest levels of obesity were among the highest 
educated, but the highest was the proportion of overweight. Metabolic diseases 
were higher in higher BMI categories. 
According to the method used, 0.73% of GDP in 2012 and 11.6% of health 
expenditure were spent on treating obesity and complications. This amount of 
money was HUF 207 bn for public expenditures and at least HUF 22 bn for 
individual expenditures. 
 In the 2013 data, public spending on health is nearly HUF 60 billion and an 
additional contribution of HUF 25 billion from patients, which is 9.3% of the 
total E fund and 0.28% of GDP. The difference between the financing data for 
the two years examined is that for 2012, the National Health Insurance Fund 
provided the total amount of payments for all cases of illness, as well as the 
accompanying diagnosis, while in 2013 only the diagnosis was the leading 
diagnosis. labeled. 
Foods from organic food have proved to be the most expensive diet, and the 
second is the diet for people with diabetes. Calorie-eating has also proved to be a 
costly diet; the cheapest was a balanced, low-energy diet. 
Increasing numbers of overweight and obese people need more attention in 
health, society, and higher awareness. The financial consequences of obesity and 
overweight are very significant, both in terms of the state budget and the 
contribution of the population. 
On this basis, we can say that the money spent on obesity and co-morbidity 
at the national economy is about 1% of GDP. 
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